Search Results

Displaying Results 3576-3600 of 3769 "'PHD'"

Oct 09, 2025, 06:07 ET Scottsdale's Xcellerant Ventures Launches Jetstream Venture Fund, Expanding Access to VC-Style Investing

to investing; giving investors access to the kind of opportunities that can transform industries." Joining him is Chris Yoo, PhD, a scientist, entrepreneur, and venture investor with a background in bioinformatics and commercialization, Doug Sylvester, JD, LLM, a visionary leader

More news about: Xcellerant Ventures


Oct 09, 2025, 06:00 ET Turbine Launches Collaboration with AstraZeneca, Leveraging Turbine's Virtual Disease Models to Rationalize ADC Discovery

experimental screening toward a more efficient, targeted strategy that selects the ADC combinations most likely to succeed in patients," said Daniel Veres, MD, PhD, CSO and Co-Founder of Turbine. "This also lays the groundwork for deeper integration of our Virtual Lab into discovery workflows, helping ensure that

More news about: Turbine


Oct 09, 2025, 06:00 ET Allelica Launches AbsoluteDx: The Most Comprehensive Genetic Risk Assessment, Combining Monogenic and Polygenic Insights Across Multiple Diseases

that integrates both monogenic and polygenic insights to make preventive medicine precise, actionable, and truly personalized," said Giordano Bottà, PhD, CEO of Allelica. "By uniting monogenic and polygenic risk assessment in one test, we're giving providers a powerful, clinically actionable tool to reduce

More news about: Allelica, Inc.


Oct 09, 2025, 03:30 ET Resolution Therapeutics announces upcoming presentations at the American Association for the Study of Liver Disease (AASLD) The Liver Meeting® 2025

2025. The conference will take place in Washington D.C., between 7-11 November 2025. Dr Paul Brennan MD, PhD, Clinical Lecturer in Hepatology, University of Dundee, UK, will present data from the University of Edinburgh's MATCH 2 clinical trial demonstrating

More news about: Resolution Therapeutics


Oct 08, 2025, 19:05 ET EMA Wellness Bolsters Executive Leadership to Scale its Market Leading Clinical Trial Platform

and CRO partners announces the appointments of Dr. Andrew Cutler, MD as Chief Medical Officer, Dr. Miranda Mann, PhD as Executive Vice President of Operations and Dr. Patrick Harrington, PhD as Senior Vice President of Clinical Solutions. Dr Cutler's clinical research track record and experience as a thought

More news about: EMA Wellness


Oct 08, 2025, 16:31 ET Breakthrough Lectures to Headline the 2025 World Congress of Neurology in Seoul

"What do we know and What Would We Like to Know about Cellular Senescence in the Brain," Dr. Mikolaj Ogrodnik, PhD, Ludwig Boltzmann Institute for Traumatology, Austria "New Therapies in Autoimmune Neurology: Focus

More news about: World Federation of Neurology


Oct 08, 2025, 16:30 ET Breakthrough Lectures to Headline the 2025 World Congress of Neurology in Seoul

"What do we know and What Would We Like to Know about Cellular Senescence in the Brain," Dr. Mikolaj Ogrodnik, PhD, Ludwig Boltzmann Institute for Traumatology, Austria "New Therapies in Autoimmune Neurology: Focus

More news about: World Federation of Neurology


Oct 08, 2025, 16:00 ET Visionary Holdings Inc. Announces 2025 Annual Meeting of Shareholders

since March 2020, the Chairman of the Board of Directors for the Canadian Youth Education Mutual Aid Association. Dr. Zhou is pursuing her doctorate (PhD Candidate) degree from Jinan University in China. Kealey Donald M, Vice Chairman

More news about: Visionary Holdings Inc.


Oct 08, 2025, 15:59 ET Physician and New York Times Bestselling Author Dr. Michael Greger Releases New Book

as low as possible, regardless of whether they are already on medications or not. Written by Dr. Greger, with Kristine Dennis, PhD, MPH, this primer lays out the risks and benefits of statin drugs and who should take them, before diving into detailing the diet best proven to lower

More news about: NutritionFacts


Oct 08, 2025, 12:42 ET Tutera Senior Living & Health Care Expands Portfolio with 26 New Senior Living Communities

Strategic Growth with the Right Partner "We grow in areas where we know we can be most successful," said Randy Bloom, PhD, President & COO of Tutera Senior Living & Health Care. "Our partnership with Diversified Healthcare Trust is built on shared philosophies –

More news about: Tutera Senior Living & Health Care


Oct 08, 2025, 11:00 ET Rosalind Franklin University Launches Doctor of Nursing Practice Program in Adult-Gerontology Acute Care

patient care environments. "Our students come to us with a deep commitment to their patients and communities," said Lisa Hopp, PhD RN FAAN, Dean of the College of Nursing. "This program was designed with them in mind, today's learners who need flexibility, support, and meaningful

More news about: Rosalind Franklin University of Medicine and Science


Oct 08, 2025, 10:00 ET GenoPalate Advances Its Science Again With Diet Snapshot

medications. "We are moving beyond being known only for genetics to leading in personalized nutrition," said Hector Guillen, PhD, Chief Scientific Officer at GenoPalate. "Diet Snapshot, combined with coaching programs centered on real-world outcomes, helps people make better choices

More news about: GenoPalate


Oct 08, 2025, 09:31 ET India's No: 1 Ranked Institute, IIT Madras & Danish University Study reveals Genetic 'Switches' that can transform Disease Research

decoding how multiple genes combine to modify and improve complex phenotypes. The research was led by Mr. Srijith Sasikumar, a PhD student, and Prof. Himanshu Sinha, from the Department of Biotechnology, IIT Madras, in collaboration with Dr. Shannara Taylor Parkins and Dr. Suresh

More news about: IIT Madras


Oct 08, 2025, 09:31 ET Florida Cancer Specialists & Research Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats

Trevor Heritage, PhD. "Practicing strong cybersecurity is critical to minimize information security risk and protect our organization and partners. The certification demonstrates

More news about: Florida Cancer Specialists & Research Institute


Oct 08, 2025, 09:26 ET India's No: 1 Ranked Institute, IIT Madras & Danish University Study reveals Genetic 'Switches' that can transform Disease Research

decoding how multiple genes combine to modify and improve complex phenotypes. The research was led by Mr. Srijith Sasikumar, a PhD student, and Prof. Himanshu Sinha, from the Department of Biotechnology, IIT Madras, in collaboration with Dr. Shannara Taylor Parkins and Dr. Suresh

More news about: IIT Madras


Oct 08, 2025, 09:00 ET Pallie Users Walk 21% More: First Proof AI Conversation Drives Lasting Behavior Change

revoke permissions or request complete data deletion at any time. For Principal Health Data Researcher Alexander Tataraidze, PhD, Pallie's support has been game-changing. "At the AIDA Freediving World Cup, I set six national records, three personal bests, and won three medals,"

More news about: AI Companions, Inc.


Oct 08, 2025, 09:00 ET Create Wellness Introduces Creatine Gummies to Target Stores Nationwide

Dr. Abbie Ryan-Smith, PhD, CSCS, and

More news about: Create Wellness


Oct 08, 2025, 09:00 ET New Research Reveals AI is Changing Hospital Hiring Expectations for Nurse Graduates

across healthcare settings. "Healthcare is changing rapidly, and nursing education must keep pace," said Dr. Christine Heid, PhD, MSN/Ed, RN, CNE, CHSE, Nursing Simulation Specialist at UbiSim. "Our research shows that while new graduates bring strong textbook knowledge, 62% of

More news about: UbiSim


Oct 08, 2025, 09:00 ET Hill's Pet Nutrition anuncia el Simposio global de Hill's 2025 - "Strong Science, Long Lives" - para avanzar en el cuidado de mascotas senior

longevidad. Oradora principal Natasha Olby, Vet MB, PhD, MRCVS, DACVIM (Neurology), profesora de neurología veterinaria y neurocirugía en la Universidad

More news about: Hill's Pet Nutrition


Oct 08, 2025, 09:00 ET The Galien Foundation Announces 2025 Prix Galien USA Nominees for the Prix Galien EcoHealth Award

Peace PrizeProfessor of Practice of Diplomacy and Conflict Resolution at NYU Abu Dhabi Pr. Awa Marie Coll-Seck, MD, PhD Former Senior Minister to the President of SenegalFormer Minister of HealthChair of Galien Africa Judith

More news about: The Galien Foundation


Oct 08, 2025, 08:42 ET Industry Leaders Launch Next-Gen Sustainability Consultancy, Solen Works, for Building Projects, Firms and Climate Innovation

Oct. 8, 2025 /PRNewswire/ -- Sustainability industry leaders Gunnar Hubbard, FAIA, LEED Fellow, and Michael Pulaski, PhD, have launched Solen Works, a sustainability consulting company that will provide project consulting and advisory services to help architecture and engineering

More news about: Solen Works


Oct 08, 2025, 08:30 ET ICH GCP E6(R3): Navigating the New Era of Good Clinical Practice, Upcoming Webinar Hosted by Xtalks

Citeline; and Pierre Mermet-Bouvier, PhD, Senior Manager, eClinical Strategy & Delivery, ICON plc, for the live webinar on Friday, October 24, 2025, at 11am EDT (5pm CEST/EU-Central).

More news about: Xtalks


Oct 08, 2025, 08:01 ET TransCode Therapeutics (RNAZ) announces the acquisition of Polynoma and a $25 Million strategic financing by a subsidiary of CK Life Sciences to form a first-in-class unique immuno-oncology and metastatic prevention oncology company

3-ready seviprotimut-L, a novel polyvalent shed antigen vaccine for the adjuvant treatment of melanoma Philippe Calais, PharmD, PhD, becomes Chief Executive Officer and remains Chairman of the Board. Tom Fitzgerald, MBA, remains Chief Financial Officer. Elizabeth Czerepak, MBA, appointed

More news about: TransCode Therapeutics, Inc.


Oct 08, 2025, 08:00 ET BIOVAXYS APPOINTS FORMER SANOFI VACCINES EXECUTIVE TO BOARD OF DIRECTORS

/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB:BVAXF) ("BioVaxys" or "Company") is pleased to announce that James Tartaglia, PhD, a former top R&D and commercial development executive with Sanofi Vaccines, has been appointed to the BioVaxys Board of Directors.  Dr. Tartaglia

More news about: BioVaxys Technology Corp.


Oct 08, 2025, 08:00 ET Arthrosi Secures $153 Million in Series E Financing to Complete Pivotal Development of Pozdeutinurad for the Treatment of Gout and Tophaceous Gout

part of comprehensive gout treatment and prevention strategies. Arthrosi Contact: Shunqi Yan, PhD Founder & Chief Operating Officer [email protected]

More news about: Arthrosi Therapeutics


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.